Tumor Necrosis Factor Action in Cells

肿瘤坏死因子在细胞中的作用

• 批准号: 6712832
• 负责人: DAVID B DONNER
• 金额: $ 33.53万
• 依托单位: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-02-01 至 2007-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6712832
• 关键词: JAK kinase; apoptosis; biological signal transduction; cell death; cell line; cytokine receptors; enzyme activity; genetic transcription; guanosinetriphosphatases; immunogenetics; mitogen activated protein kinase; nuclear factor kappa beta; phosphatidylinositol 3 kinase; protein protein interaction; protein structure function; protein tyrosine kinase; protein tyrosine phosphatase; receptor binding; receptor coupling; transfection; tumor necrosis factor alpha

Tumor necrosis factor (TNF) is a cytokine with the potential for the treatment of cancer that also promotes immunity, metabolic changes that accompany disease states, insulin resistance, inflammation, angiogenesis and wound healing. To realize the potential of TNF as a therapeutic agent, to attenuate its pathological activities and promote its beneficial effects requires insight into how TNF works. The first step in TNF action is binding to either of two receptors. The type 1 TNF receptor (TNFR1) promotes apoptosis in malignancies, fibroblast proliferation, antiviral responses, activation of a group of transcription factors, and plays a predominant role in the host defense against microorganisms. For this reason, this proposal focuses on how TNFR1 mediates its effects. Most recent work has focused on association of TNFR1 with a group of intracellular proteins that contain a death domain motif and the role of these proteins in TNF action. My laboratory has found that the TNFR1 signaling complex is composed of more proteins than previously appreciated. We have found that the TNFR1 complex contains Jak kinase, c-Src, a non-receptor tyrosine kinase, SHP-1, a protein tyrosine phosphatase, phosphatidylinositol 3-kinase, a lipid kinase, and Rac1, a GTPase. These newly identified components of the TNFR1 complex play a role in activation of NF-kappaB, a transcription factor important to immunity and cell survival. It is likely that Rac1 plays a role in coupling TNFR1 to activate p38 MAPK and JNK kinases that activate transcription factors important to stress responses. The aims of this proposal are to determine how the TNFR1 complex forms and couples to pathways that generate TNF responses and how the complex determines whether cells live or die.

肿瘤坏死因子（TNF）是一种具有治疗癌症潜力的细胞因子，其还促进免疫、伴随疾病状态的代谢变化、胰岛素抵抗、炎症、血管生成和伤口愈合。为了实现TNF作为治疗剂的潜力，减弱其病理活性并促进其有益作用，需要深入了解TNF如何起作用。 TNF作用的第一步是与两种受体中的任一种结合。 1型TNF受体（TNFR 1）促进恶性肿瘤中的细胞凋亡、成纤维细胞增殖、抗病毒应答、一组转录因子的活化，并且在宿主防御微生物中起主要作用。 因此，该提案重点关注TNFR 1如何介导其影响。 最近的工作主要集中在TNFR 1与一组含有死亡结构域基序的细胞内蛋白质的关联以及这些蛋白质在TNF作用中的作用。 我的实验室发现TNFR 1信号复合物由比以前认识到的更多的蛋白质组成。 我们已经发现TNFR 1复合物含有Jak激酶、c-Src（一种非受体酪氨酸激酶）、SHP-1（一种蛋白酪氨酸磷酸酶）、磷脂酰肌醇3-激酶（一种脂质激酶）和Rac 1（一种GT3）。 TNFR 1复合物的这些新鉴定的组分在NF-κ B的活化中起作用，NF-κ B是对免疫和细胞存活重要的转录因子。Rac 1可能在偶联TNFR 1以激活p38 MAPK和JNK激酶中起作用，所述p38 MAPK和JNK激酶激活对应激反应重要的转录因子。 该提案的目的是确定TNFR 1复合物如何形成并与产生TNF反应的途径偶联，以及复合物如何决定细胞的存活或死亡。